Akut limfoid leukémia (ALL): vizsgálatok itt: Hongkong
6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleNewly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
- Where
- Hong Kong
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06764238 - 2. fázisNot yet taking people in HongkongAsciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 45
- Run by
- The University of Hong Kong
See details and how to joinNCT07493408 - 3. fázisTaking peopleNewly-diagnosed Pediatric Ph-positive B-ALL Protocol
- Where
- Hong Kong
- Életkor
- 1 hónap to 18 év
- People
- 150 worldwide
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07152041 - 2/3. fázisTaking peopleNewly-diagnosed Pediatric T-cell ALL Protocol
- Where
- Hong Kong
- Életkor
- 1 hónap to 18 év
- People
- 610 worldwide
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06855810 - 2/3. fázisTaking peopleNewly-diagnosed Low Risk Pediatric B-cell ALL Protocol
- Where
- Hong Kong
- Életkor
- 1 év to 18 év
- People
- 3000 worldwide
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06882057 - No phaseTaking peopleCD-19 CAR-T Cell for Pediatric ALL or Lymphoma
- Where
- Hong Kong
- Életkor
- 1 év to 17 év
- People
- 18
- Run by
- Hong Kong Children's Hospital
See details and how to joinNCT06866873